MedTrace Logo

Gamification and Physical Activity in PD

NCT07286994 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-12-16

No results posted yet for this study

Summary

Despite overwhelming evidence that exercise can improve motor and non-motor symptoms of Parkinson's Disease (PD), less than 25% of Veterans with PD meet recommended activity goals. Interventions to increase PA that are scalable and can be deployed in the community represent a major opportunity. The investigators' preliminary work has demonstrated that gamification, a method commonly used for health promotion, can lead to increases in physical activity in PD. In this study, the investigators will test the effectiveness of gamification in a randomized trial to increase activity. Importantly, the investigators will also examine the effect of step count and exercise intensity on clinical outcomes and explore factors important to widespread implementation of the program VA.

Conditions

  • Parkinson Disease

Interventions

BEHAVIORAL

Gamification

Subjects will participate in an automated gamification intervention with loss or gain of points based on reaching a step goal target

BEHAVIORAL

Feedback control

Subjects in the control group will only receive a daily text message reminding them of their daily step goal and whether they met the goal or not

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • James F Morley, MD · Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2029-09-30
Completion
2030-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07286994 on ClinicalTrials.gov